Clinical Trial Update: Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating reactogenicity and immunogenicity of a delayed COVID-19 vaccine schedule in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 in Children

Snippet

Sponsor: KK Women's and Children's Hospital | Conditions: Vaccine Reaction, COVID-19 | Phase 4 | Status: UNKNOWN